Comments
G V Prasad, Chairman and CEO of Dr Reddy’s Laboratories Ltd has described the deal for acquisition of Ranbaxy by Sun Pharmaceuticals Industries as a "great move''.
In a statement released here on Monday, Prasad said: "Great move by Sun. Consistent with their strategy of acquiring distressed assets and turning them around.’’
Sun Pharma announced today that it has entered into an agreement to buy out Ranbaxy Laboratories Ltd for $4 billion.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.